Buscar en
Medicina Clínica (English Edition)
Toda la web
Inicio Medicina Clínica (English Edition) Multiple sclerosis in ophthalmology: Beyond optic neuritis
Journal Information
Vol. 155. Issue 2.
Pages 70-76 (July 2020)
Share
Share
Download PDF
More article options
Visits
4
Vol. 155. Issue 2.
Pages 70-76 (July 2020)
Review
Multiple sclerosis in ophthalmology: Beyond optic neuritis
La esclerosis múltiple en oftalmología: más allá de la neuritis óptica
Visits
4
Rafel Alcubierrea,
Corresponding author
, Bernardo F. Sánchez-Dalmaub, Silvia Muñozc
a Departamento de Oftalmología, Hospital Moisès Broggi Sant Joan Despi, Consorci Sanitari Integral, Barcelona, Spain
b Institut Clínic d’Oftalmologia (ICOF), Hospital Clínic, Barcelona, Spain
c Departamento de Oftalmología, Hospital Universitari de Bellvitge, L’Hospitalet de Llobregat, Barcelona, Spain
This item has received
Article information
Abstract
Full Text
Bibliography
Download PDF
Statistics
Figures (6)
Show moreShow less
Additional material (1)
Abstract

Disorders of the visual system are one of the main features of multiple sclerosis (MS), and have a great impact on the quality of life of patients.

Although optic neuritis is the most frequent manifestation, there are other ophthalmological processes not related to neuritis, a knowledge of which is very useful in the management of patients with MS. These abnormalities are described, grouped into impairments of the afferent pathway, efferent pathway, or upper cerebral areas. Additionally, the main ophthalmological side effects of the drugs currently used in the control of MS are described.

Keywords:
Multiple sclerosis
Optic neuropathy
Uveitis
Diplopia
Nystagmus
Treatment
Resumen

Las alteraciones del sistema visual son uno de los principales rasgos de la esclerosis múltiple (EM), y conllevan un gran impacto en la calidad de vida de los pacientes.

Aunque la neuritis óptica es la manifestación más frecuente, existen otros procesos oftalmológicos no relacionados con la neuritis, cuyo conocimiento es de gran utilidad en el manejo de los pacientes con EM. Se describen estas anomalías agrupadas en alteraciones de vía aferente, de vía eferente, y de áreas superiores cerebrales. Adicionalmente, se describen los principales efectos secundarios oftalmológicos de los fármacos actualmente empleados en el control de la EM.

Palabras clave:
Esclerosis múltiple
Neuropatía óptica
Uveítis
Diplopía
Nistagmo
Tratamiento

Article

These are the options to access the full texts of the publication Medicina Clínica (English Edition)
Subscriber
Subscriber

If you already have your login data, please click here .

If you have forgotten your password you can you can recover it by clicking here and selecting the option “I have forgotten my password”
Subscribe
Subscribe to

Medicina Clínica (English Edition)

Purchase
Purchase article

Purchasing article the PDF version will be downloaded

Price 19.34 €

Purchase now
Contact
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
E-mail
Article options
Tools
Supplemental materials
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos

Quizás le interese:
10.1016/j.medcle.2019.05.018
No mostrar más